Recent research has pointed to aldehyde dehydrogenase 1A3 (ALDH1A3) as a key factor in preserving mesenchymal GBM CSC properties,23 but the overall processes of ALDH1A3 ectopic expression are still a mystery. The gene discussed is ALDH1A3; the disease is glioblastoma.